XLV (XLV)

The article provides a detailed profile of the State Street Health Care Select Sector SPDR ETF (XLV), highlighting its investment strategy, holdings, and financial performance. It covers key statistics such as Assets Under Management (AUM), dividend yield, expense ratio, and details on its top holdings and regional exposure. The profile also addresses frequently asked questions regarding XLV's investments, dividends, and market performance.

This article examines investment options for capitalizing on the booming GLP-1 obesity drug market, dominated by Eli Lilly and Novo Nordisk. While the broad Health Care Select Sector SPDR Fund (XLV) offers diluted exposure, the specialized LeaderShares Dr. Bill Grace Global Obesity ETF (OZEM) provides more concentrated holdings in these key drugmakers. However, direct investment in companies like Eli Lilly has significantly outperformed both ETFs, highlighting trade-offs between diversification and focused growth.

The healthcare sector has significantly underperformed the broader market in 2026, with the Health Care Select Sector SPDR Fund (XLV) down approximately 1% year-to-date. This stagnation has led to several high-margin healthcare operators trading at undervalued forward multiples, presenting an opportunity for long-term investors seeking discounted entry points. The article suggests that selective stock-picking within the healthcare sector may yield above-average returns as sentiment eventually shifts.

The Health Care Select Sector SPDR Fund (XLV) has lagged in 2026, leading to several high-margin healthcare operators trading at attractive forward multiples. This article highlights three "ridiculously cheap" healthcare stocks to consider buying in June, based on their valuations and analyst ratings. These include Novo Nordisk (NVO) with a low price-to-free-cash-flow and high free cash flow yield, and CVS Health (CVS) despite XLV's flat performance, indicating strong analyst confidence.

UnitedHealth Group and Eli Lilly are at the forefront of a healthcare sector rally, as investors shift towards defensive stocks due to volatility in technology and AI. The Health Care Select Sector SPDR Fund has seen gains, indicating improving momentum for the sector. Both companies, highly rated by Seeking Alpha Quant, saw their stock prices rise in recent trading.